TrialJournal of the American Heart Association2017

Ranolazine in Symptomatic Diabetic Patients Without Obstructive Coronary Artery Disease: Impact on Microvascular and Diastolic Function.

Nishant R Shah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.